What is Olga Kaliebe's NPI number?

Olga Kaliebe's National Provider Identifier (NPI) is 1003810417, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Olga Kaliebe's specialty?

Olga Kaliebe is listed in the NPPES registry with a primary specialty of Endocrinology, Diabetes & Metabolism Physician (Allopathic & Osteopathic Physicians).

Where is Olga Kaliebe located?

Olga Kaliebe's practice location on file with NPPES is 2919 W Swann Ave Ste 105b, Tampa, FL 33609-4049.

What is Olga Kaliebe's phone number?

The practice phone number listed in the NPPES registry for Olga Kaliebe is (813) 392-1900.

Does Olga Kaliebe accept Medicare?

Olga Kaliebe is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Olga Kaliebe's NPI active?

Yes — Olga Kaliebe's NPI (1003810417) is active in the NPPES registry as of the last update on 2025-01-29.

IndividualActiveAccepts Medicare

Olga Kaliebe, MD

NPI 1003810417 · Endocrinology, Diabetes & Metabolism Physician · Tampa, FL

Olga Kaliebe, MD is a Endocrinology, Diabetes & Metabolism Physician provider in Tampa, FL (NPI 1003810417).

Provider details

NPI number: 1003810417
Entity type: Individual
Primary specialty: Endocrinology, Diabetes & Metabolism PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Female
Sole proprietor: Yes
License: ME129394 (FL)

Practice location

2919 W Swann Ave Ste 105b

Tampa, FL 33609-4049

Phone: (813) 392-1900

Fax: (813) 392-1901

Street-level locationGet directions

More FL providers

Mailing address

2919 W Swann Ave Ste 105b

Tampa, FL 33609-4049

Specialties & taxonomies

Endocrinology, Diabetes & Metabolism PhysicianPrimary207RE0101XLicense ME129394 (FL)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Endocrinology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(72/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
21 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
274 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	143	$124
New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204	69	$164
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	62	$88

Typical Medicare-allowed amounts for these services range $88–$164 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, not a price quote and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 22 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Levothyroxine Sodium	184	57
Empagliflozinbrand: Jardiance	126	40
Semaglutidebrand: Ozempic	90	23
Metformin Hclbrand: Metformin Hcl Er	67	22
Metformin Hcl	46	16
Levothyroxine Sodiumbrand: Synthroid	37

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,351 across 46 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2005-06-13
Last updated: 2025-01-29
Certified: 2025-01-29

Frequently asked questions

What is Olga Kaliebe's NPI number?: Olga Kaliebe's National Provider Identifier (NPI) is 1003810417, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Olga Kaliebe's specialty?: Olga Kaliebe is listed in the NPPES registry with a primary specialty of Endocrinology, Diabetes & Metabolism Physician (Allopathic & Osteopathic Physicians).
Where is Olga Kaliebe located?: Olga Kaliebe's practice location on file with NPPES is 2919 W Swann Ave Ste 105b, Tampa, FL 33609-4049.
What is Olga Kaliebe's phone number?: The practice phone number listed in the NPPES registry for Olga Kaliebe is (813) 392-1900.
Does Olga Kaliebe accept Medicare?: Olga Kaliebe is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Olga Kaliebe's NPI active?: Yes — Olga Kaliebe's NPI (1003810417) is active in the NPPES registry as of the last update on 2025-01-29.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	143	$124
New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204	69	$164
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	62	$88

Drug

Part D claims (2024)

Beneficiaries

Levothyroxine Sodium

184

Empagliflozinbrand: Jardiance

126

Semaglutidebrand: Ozempic

Metformin Hclbrand: Metformin Hcl Er

Metformin Hcl

Levothyroxine Sodiumbrand: Synthroid

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,351 across 46 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments